Sigma receptors and neurological disorders
- PMID: 34350561
- PMCID: PMC8641430
- DOI: 10.1007/s43440-021-00310-7
Sigma receptors and neurological disorders
Abstract
Sigma receptors were identified relatively recently, and their presence has been confirmed in the central nervous system and peripheral organs. Changes in sigma receptor function or expression may be involved in neurological diseases, and thus sigma receptors represent a potential target for treating central nervous system disorders. Many substances that are ligands for sigma receptors are widely used in therapies for neurological disorders. In the present review, we discuss the roles of sigma receptors, especially in the central nervous system disorders, and related therapies.
Keywords: Central nervous system; Neurological disorders; Sigma receptors; Sigma receptors agonists; Sigma receptors antagonists.
© 2021. The Author(s).
References
-
- Martin WR, Eades CG, Thomson JA, Huppler RE, Gilbert PE. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Therap. 1976;197(3):517–532. - PubMed
-
- Crawford KW, Bowen WD. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res. 2002;62(1):313–322. - PubMed
-
- Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, Bowen WD. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol. 1994;268(1):9–18. - PubMed
-
- Hashimoto K. Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. Prog Neurobiol. 2013;100:15–29. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources